
About DVx
DVx is a publicly listed company based in Toshima (Japan) founded in 2004. Medical devices are imported, exported, manufactured, and serviced by DVx. The company has 334 employees. Its focus areas include Diversified Medical Devices.
Company details
DVx was founded in 2004 in Toshima City, Japan, within the medical devices sector. Import and export of devices such as pacemakers, ICDs, electrode catheters, ablation catheters, and excimer lasers are handled by the company. RD manufacturing, sales, repair, and leasing services are offered, alongside general consulting, medical publishing, and market research. Internal and external peripheral services are also provided.
- Headquarters Toshima, Japan
- Employees 334
- Stage Public
- SectorsHealthcare
- Website dvx.jp
- Legal Name Dvx Inc.
- Annual Revenue$336.74 M (USD)9.75as on Mar 31, 2025
- Net Profit$2.74 M (USD)137.18as on Mar 31, 2025
- EBITDA$7.5 M (USD)2.75as on Mar 31, 2025
- Employee Count334
IPO & Listings of DVx
DVx is a publicly listed company on the TSE with ticker symbol 3079 in Japan, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Jul 2013
- Listed onTSE: 3079
- Listed entityDVx Inc.
- Exchange sectorDistribution services
- ISINJP3548710007
- Share price1,000.00 JPY (-0.3% on the day) · 2026-05-11
- Market capitalisation10,368,970,298.00 JPY
- Price to earnings33.9
- EPS (diluted, trailing year)29.46 JPY
- Dividend yield4.99%
- Volume (last session)7,300
- Analyst consensusNo rating
Financials of DVx
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | 50.32B JPY | 410.1M JPY | 1.12B JPY |
| 2023 | 45.85B JPY | 172.9M JPY | 1.09B JPY |
| 2022 | 47.48B JPY | 936.2M JPY | 1.73B JPY |
| 2021 | 45.50B JPY | 863.0M JPY | 1.62B JPY |
| 2020 | 41.01B JPY | 572.4M JPY | 1.23B JPY |
Detailed financial statements for DVx
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of DVx
The website of DVx (dvx.jp) receives about 4.2K visits a month.
- Monthly visits4.2K
▲ 14.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dvx
Complete news archive for DVx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DVx
DVx was founded in 2004.
DVx is headquartered in Toshima, Japan. It is registered at Toshima, Tokyo, Japan.
DVx has 334 employees.
Annual revenue of DVx is $336.74M as on Mar 31, 2025.
DVx was founded in 2004 in Toshima City, Japan, within the medical devices sector. Import and export of devices such as pacemakers, ICDs, electrode catheters, ablation catheters, and excimer lasers are handled by the company. RD manufacturing, sales, repair, and leasing services are offered, alongside general consulting, medical publishing, and market research. Internal and external peripheral services are also provided.
Yes, DVx is publicly traded on TSE under the ticker symbol 3079.
